Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Bertolini

Showing results (121-130 of 151) with videos related to

Pageof 16
Sort By:
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|June 6, 2020
A comparison of chemo-free strategy with G-CSF plus plerixafor on demand versus intermediate-dose cyclophosphamide and G-CSF as PBSC mobilization in newly diagnosed multiple myeloma patients: An Italian explorative cost AnalysisD Laszlo, G P Marcacci, M Martino, et al.
Leukemia Research|August 4, 2009
Expression of the human concentrative nucleotide transporter 1 (hCNT1) gene correlates with clinical response in patients affected by Waldenström's Macroglobulinemia (WM) and small lymphocytic lymphoma (SLL) undergoing a combination treatment with 2-chloro-2'-deoxyadenosine (2-CdA) and RituximabC Rabascio, D Laszlo, G Andreola, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|August 22, 2019
Correction to: Gr-MDSC-linked asset as a potential immune biomarker in pretreated NSCLC receiving nivolumab as second-line therapyA Passaro, P Mancuso, S Gandini, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|June 30, 2019
Gr-MDSC-linked asset as a potential immune biomarker in pretreated NSCLC receiving nivolumab as second-line therapyA Passaro, P Mancuso, S Gandini, et al.
Diabetes, Obesity & Metabolism|March 18, 2011
Optimized glycaemic control achieved with add-on basal insulin therapy improves indexes of endothelial damage and regeneration in type 2 diabetic patients with macroangiopathy: a randomized crossover trial comparing detemir versus glargineG P Fadini, S V de Kreutzenberg, V Mariano, et al.
British Journal of Cancer|November 26, 2009
Sorafenib in patients with advanced biliary tract carcinoma: a phase II trialC Bengala, F Bertolini, N Malavasi, et al.
Bone Marrow Transplantation|August 1, 1996
Unrelated mismatched cord blood transplantation in an adult with secondary AMLG Lambertengh Deliliers, D Soligo, A Della Volpe, et al.
Meat Science|December 3, 2014
The MC4R c.893G>A mutation: a marker for growth and leanness associated with boar taint odour in Belgian pig breedsM Schroyen, S Janssens, A Stinckens, et al.
British Journal of Cancer|January 1, 1997
Collection of circulating progenitor cells after epirubicin, paclitaxel and filgrastim in patients with metastatic breast cancerP Pedrazzoli, C Perotti, G A Da Prada, et al.
Blood|April 15, 1997
Megakaryocytic progenitors can be generated ex vivo and safely administered to autologous peripheral blood progenitor cell transplant recipientsF Bertolini, M Battaglia, P Pedrazzoli, et al.
Pageof 16

Showing results (121-130 of 151) with videos related to

Sort By:
Pageof 16
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|June 6, 2020
A comparison of chemo-free strategy with G-CSF plus plerixafor on demand versus intermediate-dose cyclophosphamide and G-CSF as PBSC mobilization in newly diagnosed multiple myeloma patients: An Italian explorative cost AnalysisD Laszlo, G P Marcacci, M Martino, et al.
Leukemia Research|August 4, 2009
Expression of the human concentrative nucleotide transporter 1 (hCNT1) gene correlates with clinical response in patients affected by Waldenström's Macroglobulinemia (WM) and small lymphocytic lymphoma (SLL) undergoing a combination treatment with 2-chloro-2'-deoxyadenosine (2-CdA) and RituximabC Rabascio, D Laszlo, G Andreola, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|August 22, 2019
Correction to: Gr-MDSC-linked asset as a potential immune biomarker in pretreated NSCLC receiving nivolumab as second-line therapyA Passaro, P Mancuso, S Gandini, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|June 30, 2019
Gr-MDSC-linked asset as a potential immune biomarker in pretreated NSCLC receiving nivolumab as second-line therapyA Passaro, P Mancuso, S Gandini, et al.
Diabetes, Obesity & Metabolism|March 18, 2011
Optimized glycaemic control achieved with add-on basal insulin therapy improves indexes of endothelial damage and regeneration in type 2 diabetic patients with macroangiopathy: a randomized crossover trial comparing detemir versus glargineG P Fadini, S V de Kreutzenberg, V Mariano, et al.
British Journal of Cancer|November 26, 2009
Sorafenib in patients with advanced biliary tract carcinoma: a phase II trialC Bengala, F Bertolini, N Malavasi, et al.
Bone Marrow Transplantation|August 1, 1996
Unrelated mismatched cord blood transplantation in an adult with secondary AMLG Lambertengh Deliliers, D Soligo, A Della Volpe, et al.
Meat Science|December 3, 2014
The MC4R c.893G>A mutation: a marker for growth and leanness associated with boar taint odour in Belgian pig breedsM Schroyen, S Janssens, A Stinckens, et al.
British Journal of Cancer|January 1, 1997
Collection of circulating progenitor cells after epirubicin, paclitaxel and filgrastim in patients with metastatic breast cancerP Pedrazzoli, C Perotti, G A Da Prada, et al.
Blood|April 15, 1997
Megakaryocytic progenitors can be generated ex vivo and safely administered to autologous peripheral blood progenitor cell transplant recipientsF Bertolini, M Battaglia, P Pedrazzoli, et al.
Pageof 16